Skip to main content

Table 3 Medical treatment of 123 patients with Hypertrophic Cardiomyopathy

From: Identification of high risk patients with hypertrophic cardiomyopathy in a northern Greek population

Medication

80 (65%)

b-blocker

59 (47.9%)

verapamil

4 (3.2%)

disopyramide

3 (2.4%)

amiodaron

10 (8.1%)

diltiazem

5 (4%)

warfarin

9 (7.3%)

CEI/ARBs

13 (10.5%)

Statins

13 (10.5%)

Diuretics

8 (6.5%)

Digoxin

2 (1.6%)

Aspirin/clopidogrel

16 (13%)

No Medication

43 (35%)